Sphere Fluidics’ Cyto-Mine System Selected by FairJourney Biologics to Advance Cell Line Development Workflows

Sphere Fluidics’ Cyto-Mine System Selected by FairJourney Biologics to Advance Cell Line Development Workflows Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today…

Read MoreSphere Fluidics’ Cyto-Mine System Selected by FairJourney Biologics to Advance Cell Line Development Workflows

Automata Technologies: $40m fundraise backed by Dimension and A.P. Moller Holding, to expand growing life science lab automation offering

Automata Technologies: $40m fundraise backed by Dimension and A.P. Moller Holding, to expand growing life science lab automation offering –Automata Technologies, a leading automation company powering life sciences labs, has raised…

Read MoreAutomata Technologies: $40m fundraise backed by Dimension and A.P. Moller Holding, to expand growing life science lab automation offering

ew Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZAto Support Thyroid Eye Disease Patient Outcomes

ew Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes Horizon Therapeutics plc (Nasdaq: HZNP) today announced new…

Read Moreew Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZAto Support Thyroid Eye Disease Patient Outcomes

Cimeio Therapeutics Announces Publication of Seminal Epitope Editing Work in the Journal of Experimental Medicine

Cimeio Therapeutics Announces Publication of Seminal Epitope Editing Work in the Journal of Experimental Medicine Cimeio Therapeutics, a biotechnology company that is reimagining immunotherapy with its Shielded Cell and Immunotherapy (SCIP®)…

Read MoreCimeio Therapeutics Announces Publication of Seminal Epitope Editing Work in the Journal of Experimental Medicine

United Therapeutics Announces Recent Milestones for its Heart and Kidney Xenotransplantation Programs

United Therapeutics Announces Recent Milestones for its Heart and Kidney Xenotransplantation Programs United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the achievement of two milestones for its xenotransplantation…

Read MoreUnited Therapeutics Announces Recent Milestones for its Heart and Kidney Xenotransplantation Programs